Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (791-800 of 903) with videos related to

Pageof 91
Sort By:
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective CohortRon L H Handels, Manuela A Joore, Stephanie J B Vos, et al.
Clinical Proteomics|January 2, 2019
The plasma peptides of ovarian cancerJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Alzheimer'S Research & Therapy|October 30, 2020
Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuumMark A Dubbelman, Roos J Jutten, Sarah E Tomaszewski Farias, et al.
Nature Communications|September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationYing Jiang, John J Alam, Stephen N Gomperts, et al.
Brain : a Journal of Neurology|March 9, 2023
Genetically identical twin-pair difference models support the amyloid cascade hypothesisEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy|November 3, 2023
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET studyIlse Bader, Ilona Bader, Isadora Lopes Alves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Alzheimer'S Research & Therapy|May 25, 2019
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT studyWillem S Eikelboom, Ellen Singleton, Esther van den Berg, et al.
NMR in Biomedicine|December 20, 2014
Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive functionSanneke van Rooden, Mathijs Buijs, Marjolein E van Vliet, et al.
Pageof 91

Showing results (791-800 of 903) with videos related to

Sort By:
Pageof 91
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective CohortRon L H Handels, Manuela A Joore, Stephanie J B Vos, et al.
Clinical Proteomics|January 2, 2019
The plasma peptides of ovarian cancerJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Alzheimer'S Research & Therapy|October 30, 2020
Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuumMark A Dubbelman, Roos J Jutten, Sarah E Tomaszewski Farias, et al.
Nature Communications|September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationYing Jiang, John J Alam, Stephen N Gomperts, et al.
Brain : a Journal of Neurology|March 9, 2023
Genetically identical twin-pair difference models support the amyloid cascade hypothesisEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy|November 3, 2023
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET studyIlse Bader, Ilona Bader, Isadora Lopes Alves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Alzheimer'S Research & Therapy|May 25, 2019
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT studyWillem S Eikelboom, Ellen Singleton, Esther van den Berg, et al.
NMR in Biomedicine|December 20, 2014
Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive functionSanneke van Rooden, Mathijs Buijs, Marjolein E van Vliet, et al.
Pageof 91